Results 301 to 310 of about 267,145 (352)

CD3+ Tumor-Infiltrating Lymphocytes in Breast Carcinoma: Their Prognostic Role and Association With Clinical Parameters. [PDF]

Cureus
Chauhan R, Patil V.
europepmc   +1 more source

Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer. [PDF]

Breast Cancer Res
Han E, Choi HY, Kwon HJ, Chung YR, Shin HC, Kim EK, Suh KJ, Kim SH, Kim JH, Park SY.   +9 more
europepmc   +1 more source

An Ultrasound-based Machine Learning Model for Predicting Tumor-Infiltrating Lymphocytes in Breast Cancer. [PDF]

Technol Cancer Res Treat
Liu B, Gu X, Xie D, Zhao B, Han D, Zhang Y, Li T, Fang J.   +7 more
europepmc   +1 more source

The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+ and CD8+) on Chemotherapy Response in Colorectal Cancer Patients. [PDF]

Cancer Manag Res
Lukman K, Septianto R, Rudiman R, Ruchimat T, Sribudiani Y, Nugraha P, Primastari E, Budiman D.   +7 more
europepmc   +1 more source

Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial.

JAMA Oncol
Dieci MV, Bisagni G, Bartolini S, Schirone A, Cavanna L, Musolino A, Giotta F, Rimanti A, Garrone O, Bertone E, Cagossi K, Sarti S, Ferro A, Piacentini F, Orvieto E, Sanders M, Miglietta F, Massa D, Balduzzi S, Conte P, D'Amico R, Guarneri V.   +21 more
europepmc   +1 more source

Tumor-infiltrating lymphocytes in breast cancer through artificial intelligence: biomarker analysis from the results of the TIGER challenge

van Rijthoven M, Aswolinskiy W, Tessier L, Balkenhol M, Bogaerts JMA, Drubay D, Blesa LC, Peeters D, Stovgaard ES, Lænkholm A, Haynes H, Craciun L, Larsimont D, Amgad MT, Cooper LA, de Kock C, Dechering V, Lotz J, Weiss N, van Bockstal M, Galant C, Lips E, Horlings HM, Wesseling J, Mulder L, van den Belt S, Weber K, Jank P, Denkert C, Munari E, Bogina G, Russ C, Lemm A, Loi S, Douglas JD, Michiels S, Joensuu H, Fan M, Lee D, Ye J, Byun K, Kim J, Xu S, Ji Z, Xie F, Kuang J, Chen X, Chen L, Tsakiroglou AM, Byers R, Fergie M, Ramanathan V, Martel AL, Shephard A, Ahmed Raza SE, Jahanifar M, Rajpoot NM, Cho S, Kim D, Jang H, Park C, Kim K, Donders R, Maurits S, Groeneveld M, Mickan A, Meakin J, van Ginneken B, Salgado R, van der Laak J, Ciompi F.   +70 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer.

Annals of Surgery, 2020
OBJECTIVE To determine whether prognostic nutritional index (PNI) affects clinical outcome through local immunity in esophageal cancers. BACKGROUND PNI is an indicator of nutritional status and systemic immune competence, and has attracted attention as
K. Okadome, Y. Baba, T. Yagi, Y. Kiyozumi, T. Ishimoto, M. Iwatsuki, Y. Miyamoto, N. Yoshida, Masayuki Watanabe, H. Baba   +9 more
semanticscholar   +1 more source

Tumor microenvironment and lymphocyte infiltration

Cancer Immunology, Immunotherapy, 2012
There is ample evidence that the presence of tumor-infiltrating T lymphocytes is associated with a favorable prognostic in patients. These observations suggest that a limiting step to immune resistance and immunotherapy could be the capacity of tumor-specific T cells to reach tumor bed.
Rahir, Gwendoline, Moser, Muriel
openaire   +2 more sources

Tumor-Infiltrating Lymphocytes

The Cancer Journal, 2015
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) in combination with lymphodepletion and high-dose interleukin 2 has shown reproducible objective response rates of approximately 50% in patients with highly advanced, refractory metastatic melanoma.
Ronnie Shapira-Frommer, Jacob Schachter, Michal J. Besser   +2 more
openaire   +3 more sources

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.

Journal of the American Medical Association (JAMA)
Importance The association of tumor-infiltrating lymphocyte (TIL) abundance in breast cancer tissue with cancer recurrence and death in patients with early-stage triple-negative breast cancer (TNBC) who are not treated with adjuvant or neoadjuvant ...
R. Leon-Ferre, S. Jonas, R. Salgado, S. Loi, V. D. de Jong, Jodi M. Carter, Torsten O. Nielsen, Samuel Leung, N. Riaz, Stephen K. L. Chia, Gerome Jules-Clement, G. Curigliano, C. Criscitiello, Vincent Cockenpot, M. Lambertini, Vera J Suman, B. Linderholm, John W. M. Martens, C. V. van Deurzen, A. M. Timmermans, T. Shimoi, S. Yazaki, Masayuki Yoshida, Sung-Bae Kim, Hee Jin Lee, M. Dieci, Guillaume Bataillon, A. Vincent-Salomon, Fabrice André, M. Kok, Sabine C. Linn, M. Goetz, S. Michiels   +32 more
semanticscholar   +1 more source